Evidence map›Paper›PMID 34954118›Full record

ArticleThe Journal of molecular diagnostics : JMD2022

Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies.

Diana Y Vargas, Sanjay Tyagi, Salvatore A E Marras, Patricia Moerzinger, Juan A Abin-Carriquiry, Mauricio Cuello, Clara Rodriguez, Andrés Martinez, Alex Makhnin, Andrea Farina and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Diana Y VargasPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey.
Sanjay TyagiPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey.
Salvatore A E MarrasPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey.
Patricia MoerzingerATGen, Montevideo, Uruguay.
Juan A Abin-CarriquiryATGen, Montevideo, Uruguay.
Mauricio CuelloServicio de Oncología Clínica, Hospital de Clínicas, Montevideo, Uruguay.
Clara RodriguezServicio de Oncología Clínica, Hospital de Clínicas, Montevideo, Uruguay.
Andrés MartinezMemorial Sloan Kettering Cancer Center, New York, New York.
Alex MakhninMemorial Sloan Kettering Cancer Center, New York, New York.
Andrea FarinaMemorial Sloan Kettering Cancer Center, New York, New York.
Chintan PatelMemorial Sloan Kettering Cancer Center, New York, New York.
Tuan L ChuangMemorial Sloan Kettering Cancer Center, New York, New York.
Bob T LiMemorial Sloan Kettering Cancer Center, New York, New York; Weill-Cornell Medicine, New York, New York. Electronic address: lib1@mskcc.org.
Fred R KramerPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey. Electronic address: fred.kramer@rutgers.edu.
Memorial Sloan Kettering Cancer Center · USRutgers, The State University of New Jersey · USHospital de Clínicas · UY

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Background free amplified single-molecule FISH for in situ and flow cytometric applicationsR01CA227291 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI TYAGI, SANJAY · 2018 to 2022
$2.8M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA227291
6 · The paper itself

Abstract

SuperSelective primers, by virtue of their unique design, enable the simultaneous identification and quantitation of inherited reference genes and rare somatic mutations in routine multiplex PCR assays, while virtually eliminating signals from abundant wild-type sequences closely related to the target mutations. These assays are sensitive, specific, rapid, and low cost, and can be performed in widely available spectrofluorometric thermal cyclers. Herein, we provide examples of SuperSelective PCR assays that target eight different somatic EGFR mutations, irrespective of whether they occur in the same codon, occur at separate sites within the same exon, or involve deletions. In addition, we provide examples of SuperSelective PCR assays that detect specific EGFR mutations in circulating tumor DNA present in the plasma of liquid biopsies obtained from patients with non-small-cell lung cancer. The results suggest that multiplex SuperSelective PCR assays may enable the choice, and subsequent modification, of effective targeted therapies for the treatment of an individual's cancer, utilizing frequent noninvasive liquid biopsies.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsErbB ReceptorsHumansLiquid BiopsyMultiplex Polymerase Chain ReactionMutationErbB Receptors

Identifiers

PMID34954118
PMCPMC8961470
OpenAlexW4200359452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.